- Home
- ZNTL vs FCEL Comparison
ZNTL vs FCEL Comparison
Compare ZNTL & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- FCEL
- Stock Information
- Founded
- ZNTL 2014
- FCEL 1969
- Country
- ZNTL United States
- FCEL United States
- Employees
- ZNTL N/A
- FCEL N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- FCEL Industrial Machinery/Components
- Sector
- ZNTL Health Care
- FCEL Energy
- Exchange
- ZNTL Nasdaq
- FCEL Nasdaq
- Market Cap
- ZNTL 137.9M
- FCEL 144.6M
- IPO Year
- ZNTL 2020
- FCEL 1992
- Fundamental
- Price
- ZNTL $1.39
- FCEL $4.59
- Analyst Decision
- ZNTL Buy
- FCEL Hold
- Analyst Count
- ZNTL 8
- FCEL 6
- Target Price
- ZNTL $8.53
- FCEL $14.28
- AVG Volume (30 Days)
- ZNTL 844.8K
- FCEL 742.4K
- Earning Date
- ZNTL 03-26-2025
- FCEL 03-11-2025
- Dividend Yield
- ZNTL N/A
- FCEL N/A
- EPS Growth
- ZNTL N/A
- FCEL N/A
- EPS
- ZNTL N/A
- FCEL N/A
- Revenue
- ZNTL $67,425,000.00
- FCEL $114,438,000.00
- Revenue This Year
- ZNTL N/A
- FCEL $62.61
- Revenue Next Year
- ZNTL N/A
- FCEL $4.68
- P/E Ratio
- ZNTL N/A
- FCEL N/A
- Revenue Growth
- ZNTL N/A
- FCEL 11.09
- 52 Week Low
- ZNTL $1.36
- FCEL $4.36
- 52 Week High
- ZNTL $16.21
- FCEL $37.20
- Technical
- Relative Strength Index (RSI)
- ZNTL 30.80
- FCEL 28.28
- Support Level
- ZNTL $1.78
- FCEL $4.66
- Resistance Level
- ZNTL $2.02
- FCEL $4.99
- Average True Range (ATR)
- ZNTL 0.15
- FCEL 0.34
- MACD
- ZNTL -0.02
- FCEL -0.04
- Stochastic Oscillator
- ZNTL 4.57
- FCEL 8.16
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.